- Home
- EPOW vs BNR Comparison
EPOW vs BNR Comparison
Compare EPOW & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- BNR
- Stock Information
- Founded
- EPOW 2014
- BNR 2014
- Country
- EPOW China
- BNR China
- Employees
- EPOW N/A
- BNR N/A
- Industry
- EPOW Business Services
- BNR Medical Specialities
- Sector
- EPOW Consumer Discretionary
- BNR Health Care
- Exchange
- EPOW Nasdaq
- BNR Nasdaq
- Market Cap
- EPOW 24.5M
- BNR 38.3M
- IPO Year
- EPOW 2021
- BNR 2020
- Fundamental
- Price
- EPOW $0.91
- BNR $4.60
- Analyst Decision
- EPOW
- BNR
- Analyst Count
- EPOW 0
- BNR 0
- Target Price
- EPOW N/A
- BNR N/A
- AVG Volume (30 Days)
- EPOW 17.8K
- BNR 19.9K
- Earning Date
- EPOW 07-22-2025
- BNR 08-21-2025
- Dividend Yield
- EPOW N/A
- BNR N/A
- EPS Growth
- EPOW N/A
- BNR N/A
- EPS
- EPOW N/A
- BNR N/A
- Revenue
- EPOW $64,997,741.00
- BNR $72,112,038.00
- Revenue This Year
- EPOW N/A
- BNR $136.32
- Revenue Next Year
- EPOW N/A
- BNR N/A
- P/E Ratio
- EPOW N/A
- BNR N/A
- Revenue Growth
- EPOW 44.28
- BNR 0.53
- 52 Week Low
- EPOW $0.55
- BNR $2.18
- 52 Week High
- EPOW $1.36
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- EPOW 45.99
- BNR 68.63
- Support Level
- EPOW $0.88
- BNR $3.06
- Resistance Level
- EPOW $0.96
- BNR $4.96
- Average True Range (ATR)
- EPOW 0.06
- BNR 0.27
- MACD
- EPOW -0.00
- BNR 0.13
- Stochastic Oscillator
- EPOW 19.25
- BNR 81.05
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.